Bicocca Open Archive

Logo unimib boa
MAGISTRONI, VERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.748
EU - Europa 2.851
AS - Asia 2.218
SA - Sud America 311
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 1
Totale 11.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.598
SG - Singapore 831
CN - Cina 655
DE - Germania 603
SE - Svezia 400
RU - Federazione Russa 390
IT - Italia 375
IE - Irlanda 356
HK - Hong Kong 315
BR - Brasile 255
UA - Ucraina 230
GB - Regno Unito 181
VN - Vietnam 161
CA - Canada 115
FI - Finlandia 78
FR - Francia 64
IN - India 63
TR - Turchia 41
BE - Belgio 34
DK - Danimarca 28
ID - Indonesia 28
NL - Olanda 28
PL - Polonia 28
ZA - Sudafrica 26
KR - Corea 25
MX - Messico 24
AR - Argentina 23
BD - Bangladesh 22
JP - Giappone 18
IQ - Iraq 12
ES - Italia 11
AT - Austria 10
BG - Bulgaria 9
EU - Europa 9
LT - Lituania 9
SA - Arabia Saudita 9
EC - Ecuador 8
VE - Venezuela 7
CZ - Repubblica Ceca 6
IR - Iran 6
CH - Svizzera 5
CO - Colombia 5
PE - Perù 5
DO - Repubblica Dominicana 4
KE - Kenya 4
MA - Marocco 4
NP - Nepal 4
PK - Pakistan 4
AZ - Azerbaigian 3
CL - Cile 3
IL - Israele 3
MY - Malesia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
MU - Mauritius 2
NO - Norvegia 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 11.179
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.035
Ashburn 530
Singapore 521
Woodbridge 445
Chandler 354
Dublin 348
Fairfield 332
Hong Kong 313
Frankfurt am Main 269
Houston 268
Jacksonville 224
Wilmington 209
Dearborn 205
Milan 167
New York 152
Seattle 129
Beijing 116
Cambridge 107
Santa Clara 107
Los Angeles 100
Göttingen 91
Princeton 91
Dallas 81
Shanghai 79
Nanjing 61
Hefei 49
Ho Chi Minh City 48
Altamura 41
Munich 41
Lachine 38
Lawrence 35
Moscow 35
Brussels 34
São Paulo 33
Fürstenwalde 32
Chicago 31
Boardman 29
Dong Ket 27
Toronto 27
San Diego 26
Fremont 25
Buffalo 24
Hanoi 24
Shenyang 24
The Dalles 23
Warsaw 23
Jakarta 21
Helsinki 20
London 20
Seoul 19
Tianjin 19
Andover 18
Guangzhou 16
Montreal 16
Ottawa 16
Tokyo 16
Changsha 14
Council Bluffs 14
Huizen 14
Johannesburg 14
Nuremberg 14
Atlanta 13
Hebei 13
Jinan 13
Nanchang 13
Brooklyn 12
Jiaxing 12
Turku 12
Boston 10
Chennai 10
Kunming 10
Lissone 10
Manchester 10
Orem 10
Denver 9
Falls Church 9
Mexico City 9
Mumbai 9
Pune 9
Romola 9
Salt Lake City 9
Stockholm 9
Düsseldorf 8
Kocaeli 8
Norwalk 8
Plovdiv 8
Rome 8
San Francisco 8
Verona 8
Vienna 8
Ankara 7
Brasília 7
Haiphong 7
Nürnberg 7
Auburn Hills 6
Charlotte 6
Edmonton 6
Hangzhou 6
Kent 6
Lauterbourg 6
Totale 7.602
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 504
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 405
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 391
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 379
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 355
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 349
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 345
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 319
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 310
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 305
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 303
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 301
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al 282
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 279
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 275
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 271
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 271
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex 267
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 266
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 263
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 262
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 252
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 248
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 245
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 233
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 225
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 224
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 217
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 216
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 213
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 210
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 210
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2 201
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 194
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 183
BIM promoter is epigenetically silenced in malignant lymphoid cells, leading to downregulation of BIM expression and protection from apoptosis 181
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 178
Mechanisms of Bim epigenetic silencing in anaplastic large cell lymphoma 168
The novel PIM1 inhibitor NMS-P645 reverses PIM1-Dependent effects on TMPRSS2/ERG positive Prostate cancer cells and shows anti-proliferative activity in combination with PI3K inhibition 167
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents 161
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 152
Reactivation of an Epigenetic Silenced Tumor Suppressor Gene BIM in Anaplastic Large Cell Lymphoma Leads to massive Apoptosis 143
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 139
Epigenetic changes at the bim locus associated with glucocorticoid resistance in human lymphoid malignancies 137
Reversal of glucocorticoid resistance in human lymphoid malignancies with histone deacetylase inhibitors 136
Role of TMPRSS2/ERG in cellular transformation 126
Totale 11.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021685 0 0 0 0 0 133 105 82 96 115 63 91
2021/2022687 47 67 103 45 47 62 38 32 32 61 47 106
2022/20231.298 157 426 113 127 94 181 15 64 87 5 19 10
2023/2024930 23 32 33 47 126 285 205 15 59 16 4 85
2024/20251.716 112 190 108 102 156 58 102 31 124 314 156 263
2025/20262.260 503 222 359 564 568 44 0 0 0 0 0 0
Totale 11.461